FI873299A - Karbapenemfoerening i kristallform och dess framstaellning och anvaendning. - Google Patents

Karbapenemfoerening i kristallform och dess framstaellning och anvaendning. Download PDF

Info

Publication number
FI873299A
FI873299A FI873299A FI873299A FI873299A FI 873299 A FI873299 A FI 873299A FI 873299 A FI873299 A FI 873299A FI 873299 A FI873299 A FI 873299A FI 873299 A FI873299 A FI 873299A
Authority
FI
Finland
Prior art keywords
och
karbapenemfoerening
kristallform
anvaendning
dess framstaellning
Prior art date
Application number
FI873299A
Other languages
English (en)
Other versions
FI873299A0 (fi
FI88037C (fi
FI88037B (fi
Inventor
Makoto Sunagawa
Yutaka Isobe
Yutaka Takeuchi
Haruki Matsumura
Tetsuo Noguchi
Yukio Ozaki
Original Assignee
Sumitomo Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Pharma filed Critical Sumitomo Pharma
Publication of FI873299A0 publication Critical patent/FI873299A0/fi
Publication of FI873299A publication Critical patent/FI873299A/fi
Application granted granted Critical
Publication of FI88037B publication Critical patent/FI88037B/fi
Publication of FI88037C publication Critical patent/FI88037C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI873299A 1986-07-30 1987-07-29 Foerfarande foer framstaellning av farmaceutiskt vaerdefullt kristallint (4r,5s,6s,8r,2's,4's)-3-/4-(2-dimetylaminokarbonyl)-pyrrolidinyltio/-4-metyl-6-(1-hydroxietyl)-1-azabicyklo-/3,2,0/-hept-2-en-7-on-2-karboxylsyratrihydrat FI88037C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP17932186 1986-07-30
JP17932186 1986-07-30
JP15776987 1987-06-26
JP15776987 1987-06-26

Publications (4)

Publication Number Publication Date
FI873299A0 FI873299A0 (fi) 1987-07-29
FI873299A true FI873299A (fi) 1988-01-31
FI88037B FI88037B (fi) 1992-12-15
FI88037C FI88037C (fi) 1993-03-25

Family

ID=26485103

Family Applications (1)

Application Number Title Priority Date Filing Date
FI873299A FI88037C (fi) 1986-07-30 1987-07-29 Foerfarande foer framstaellning av farmaceutiskt vaerdefullt kristallint (4r,5s,6s,8r,2's,4's)-3-/4-(2-dimetylaminokarbonyl)-pyrrolidinyltio/-4-metyl-6-(1-hydroxietyl)-1-azabicyklo-/3,2,0/-hept-2-en-7-on-2-karboxylsyratrihydrat

Country Status (20)

Country Link
US (1) US4888344A (fi)
EP (1) EP0256377B1 (fi)
JP (1) JP2665767B2 (fi)
AR (1) AR243189A1 (fi)
AU (1) AU596857B2 (fi)
CA (1) CA1322371C (fi)
DE (1) DE3781980T2 (fi)
DK (1) DK172666B1 (fi)
ES (1) ES2052524T3 (fi)
FI (1) FI88037C (fi)
GR (1) GR3006254T3 (fi)
HK (1) HK169595A (fi)
HU (1) HU199473B (fi)
IE (1) IE60588B1 (fi)
IL (1) IL83372A (fi)
LU (1) LU88635I2 (fi)
MX (1) MX173359B (fi)
NO (2) NO165543C (fi)
NZ (1) NZ221224A (fi)
PH (1) PH24710A (fi)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1283906C (en) * 1983-05-09 1991-05-07 Makoto Sunagawa .beta.-LACTAM COMPOUNDS AND PRODUCTION THEREOF
KR880006244A (ko) * 1986-11-24 1988-07-22 후지사와 도모 기찌 로 3-피롤리디닐티오-1-아자바이스클로[3.2.0]햅트2-엔-2-카르복실산 화합물 및 이의 제조방법
EP0406863B1 (en) * 1989-07-06 1995-05-24 Banyu Pharmaceutical Co., Ltd. Cyclic amidinylthiocarbapenem derivatives
EP0435320B1 (en) * 1989-12-29 1994-10-05 Banyu Pharmaceutical Co., Ltd. 2(2-Cyclopropylpyrrolidin-4-ylthio)-carbapenem derivatives
TW264475B (fi) * 1991-09-20 1995-12-01 Takeda Pharm Industry Co Ltd
JP2696807B2 (ja) * 1992-08-06 1998-01-14 田辺製薬株式会社 カルバペネム誘導体の製法
GB9503717D0 (en) * 1995-02-24 1995-04-12 Smithkline Beecham Plc Novel compounds
FR2735474B1 (fr) * 1995-06-13 1997-08-08 Roussel Uclaf Chlorhydrate de zilpaterol sous une forme cristallisee particuliere, son procede de preparation et les produits intermediaires mis en oeuvre
YU37299A (sh) * 1997-02-07 2002-06-19 Kyoto Pharmaceutical Industries Ltd. Karbapenemsko jedinjenje, njegova primena i njegovo intermedijarno jedinjenje
AU760386B2 (en) 1998-05-01 2003-05-15 Kyoto Pharmaceutical Industries, Ltd. Carbapenem derivatives, utilization thereof and intermediate compounds of the same
US7084268B1 (en) 1999-06-03 2006-08-01 Eisai Co., Ltd. Carbapenem compound crystals and interjection preparations
US7041660B2 (en) 1999-07-06 2006-05-09 Sankyo Company, Limited Crystalline 1-methylcarbapenem derivatives
TWI250160B (en) * 1999-07-06 2006-03-01 Sankyo Co Crystalline 1-methylcarbapenem compound
DK1280531T3 (da) * 2000-05-12 2007-05-29 Novalar Pharmaceuticals Inc Formulering bestående af phentolaminmesylat og anvendelse heraf
JP5079190B2 (ja) * 2001-04-27 2012-11-21 大日本住友製薬株式会社 アゼチジノン誘導体およびその製造方法
NZ530170A (en) * 2001-05-21 2005-09-30 Kyoto Pharma Ind Carbapenem compound
KR100451672B1 (ko) * 2001-06-05 2004-10-08 한미약품 주식회사 결정성 세프디니르 산부가염, 이의 제조방법 및 이를이용한 세프디니르의 제조방법
US20040198973A1 (en) * 2001-08-13 2004-10-07 Tsujii Masahiko Process for preparation of carbapenem antibiotics
MXPA04002797A (es) * 2001-09-26 2004-07-02 Merck & Co Inc Procedimiento para elaborar compuestos de carbapenemo.
AU2002331885B2 (en) * 2001-09-26 2007-07-26 Merck & Co., Inc. Crystalline forms of ertapenem sodium
ITMI20012364A1 (it) * 2001-11-09 2003-05-09 Antibioticos Spa Processo di sintesi della cefixima via alchil-o arilsolfonati
EP2316468A1 (en) 2002-02-22 2011-05-04 Shire LLC Delivery system and methods for protecting and administering dextroamphetamine
US7229630B2 (en) * 2002-06-20 2007-06-12 Novalar Pharmaceuticals, Inc. Stabilized formulations of alpha adrenergic receptor antagonists and the uses thereof
US20030236306A1 (en) * 2002-06-20 2003-12-25 Chen Andrew X. Stabilized formulations of alpha adrenergic receptor antagonists and the uses thereof
EP1950563A3 (en) 2002-09-11 2008-08-06 Michio Ishibashi Method for screening for a substance for promoting regeneration of macrophages
WO2005118586A1 (en) * 2004-06-02 2005-12-15 Sandoz Ag Meropenem intermediate in crystalline form
WO2006035300A2 (en) * 2004-09-30 2006-04-06 Ranbaxy Laboratories Limited A process for the preparation of meropenem
JP4547245B2 (ja) * 2004-12-16 2010-09-22 株式会社パーマケム・アジア ペリンドプリルエルブミンのｉ型結晶、及びその製造方法
US7872050B2 (en) * 2005-03-14 2011-01-18 Yaupon Therapeutics Inc. Stabilized compositions of volatile alkylating agents and methods of using thereof
US8501818B2 (en) * 2005-03-14 2013-08-06 Ceptaris Therapeutics, Inc. Stabilized compositions of alkylating agents and methods of using same
US20110039943A1 (en) * 2005-03-14 2011-02-17 Robert Alonso Methods for treating skin disorders with topical nitrogen mustard compositions
US20070197781A1 (en) * 2005-07-29 2007-08-23 Neera Tewari Processes for the preparation of carbapenems
PT1926732E (pt) 2005-09-05 2013-12-27 Ranbaxy Lab Ltd Processo para a preparação de compostos de carbapenem
BRPI0616563A2 (pt) * 2005-09-15 2012-12-25 Orchid Chemicals & Pharm Ltd processo melhorado para a preparaÇço de antibiàtico betalactÂmico
CN100497338C (zh) * 2006-01-05 2009-06-10 上海医药工业研究院 4－甲基－7－氧－1－氮杂双环[3.2.0]庚－2－烯－2－羧酸类衍生物的制备方法
KR100781821B1 (ko) * 2006-02-16 2007-12-03 문순구 카르바페넴계 화합물의 제조방법
EP2006290A4 (en) * 2006-03-28 2011-01-05 Kaneka Corp IMPROVED PROCESS FOR PRODUCING CARBAPENEM COMPOUND
KR20090007572A (ko) * 2006-04-28 2009-01-19 카네카 코포레이션 카르바페넴 항생 물질 중간체의 개량된 정석 방법
EP2229944A1 (en) * 2007-12-12 2010-09-22 Dainippon Sumitomo Pharma Co., Ltd. Preparation composition
US20090216010A1 (en) * 2008-02-22 2009-08-27 Wei-Hong Tseng Crystalline carbapenem compound and produced method thereof
EP2098525A1 (en) 2008-02-26 2009-09-09 Savior Lifetec Corporation Crystalline carbapenem compound and produced method thereof
HUE053482T2 (hu) * 2008-03-27 2021-06-28 Helsinn Healthcare Sa Alkilezõszerek stabilizált készítményei és alkalmazási eljárásaik
US8097719B2 (en) * 2008-07-15 2012-01-17 Genesen Labs Meropenem intermediate in novel crystalline form and a method of manufacture of meropenem
AU2009277936B2 (en) * 2008-07-30 2014-11-27 Sun Pharmaceutical Industries Limited Process for the preparation of carbapenem compounds
CN102348710B (zh) * 2009-03-13 2014-12-17 株式会社大熊制药 利用锌粉制备美罗培南的改进方法
WO2011048583A1 (en) 2009-10-23 2011-04-28 Ranbaxy Laboratories Limited Process for the preparation of carbapenem compounds
WO2011141847A1 (en) * 2010-05-10 2011-11-17 Orchid Chemicals And Pharmaceuticals Limited An improved process for the preparation of meropenem
PL2630147T3 (pl) 2010-10-22 2015-08-31 Ranbaxy Laboratories Ltd Sposób otrzymywania czystego trihydratu meropenemu
CN101962383A (zh) * 2010-11-12 2011-02-02 上海巴迪生物医药科技有限公司 一种美罗培南的合成方法
WO2012081033A2 (en) * 2010-12-06 2012-06-21 Sequent Scientific Limited A process for preparation of imipenem
CN102532140B (zh) * 2010-12-21 2015-03-11 北大方正集团有限公司 一种美罗培南三水合物的制备方法
CN102250096B (zh) * 2011-09-05 2016-04-06 江西华邦药业有限公司 一种美罗培南的制备方法
CN103570719B (zh) * 2012-07-31 2016-03-02 深圳市海滨制药有限公司 一种美罗培南原料药、其制备方法及包含其的药物组合物
CN103570718B (zh) * 2012-07-31 2016-06-29 深圳市海滨制药有限公司 一种美罗培南原料药、其制备方法及包含其的药物组合物
CN103570720B (zh) * 2012-07-31 2016-02-10 新乡海滨药业有限公司 一种美罗培南原料药、其制备方法及包含其的药物组合物
KR101331762B1 (ko) 2012-12-28 2013-11-20 주식회사 대웅제약 메로페넴의 삼수화물의 제조방법
CN103044429B (zh) * 2013-01-28 2015-04-01 苏州二叶制药有限公司 一种美罗培南的制备方法
WO2014121027A1 (en) 2013-02-01 2014-08-07 Oculars Pharma, Llc Aqueous ophthalmic solutions of phentolamine and medical uses thereof
ES2835398T3 (es) 2013-02-01 2021-06-22 Ocuphire Pharma Inc Métodos y composiciones para la administración oftálmica diaria de fentolamina para mejorar el rendimiento visual
KR102144777B1 (ko) 2013-06-19 2020-08-18 제이더블유중외제약 주식회사 결정형 메로페넴 삼수화물의 제조방법
CN106459052B (zh) 2014-03-27 2021-07-30 庄信万丰股份有限公司 制备碳青霉烯抗生素的方法
CA3116589A1 (en) 2018-10-26 2020-04-30 Ocuphire Pharma, Inc. Methods and compositions for treatment of presbyopia, mydriasis, and other ocular disorders
CN115368310A (zh) 2021-05-18 2022-11-22 奥库菲尔医药公司 合成甲磺酸酚妥拉明的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK153486C (da) * 1978-07-03 1988-11-28 Merck & Co Inc Analogifremgangsmaade til fremstilling af krystallinsk n-formimidoyl-thienamycin-monohydrat
EP0113101A1 (en) * 1982-12-30 1984-07-11 Merck & Co. Inc. 6-(1-Hydroxyethyl)-2-SR8-1-methyl-1-carbadethiapen-2-em-3-carboxylic acid esters
CA1283906C (en) * 1983-05-09 1991-05-07 Makoto Sunagawa .beta.-LACTAM COMPOUNDS AND PRODUCTION THEREOF
JPS60104088A (ja) * 1983-11-11 1985-06-08 Sumitomo Chem Co Ltd 新規なβ−ラクタム化合物およびその製造法
US4748238A (en) * 1984-03-14 1988-05-31 Merck & Co., Inc. Crystalline 1R,5S,6S,8R-1-methyl-2-(N,N-dimethylcarbamimidoylmethylthio)-6-(1-hydroxyethyl)-1-carbapen-2-em-3-carboxylic acid
US4713451A (en) * 1984-04-09 1987-12-15 Merck & Co., Inc. Crystalline dimethyliminothienamycin
US4761408A (en) * 1984-11-02 1988-08-02 Ciba-Geigy Corporation Crystalline aminomethyl compound
NZ214691A (en) * 1984-12-27 1988-08-30 Sumitomo Pharma The preparation of carbapenem derivatives and beta-lactam intermediates
US4788282A (en) * 1985-06-07 1988-11-29 Bristol-Myers Company Deprotection of allylic esters and ethers

Also Published As

Publication number Publication date
HUT44553A (en) 1988-03-28
JP2665767B2 (ja) 1997-10-22
IE60588B1 (en) 1994-07-27
AU596857B2 (en) 1990-05-17
EP0256377A1 (en) 1988-02-24
IL83372A (en) 1992-05-25
NO165543B (no) 1990-11-19
DK172666B1 (da) 1999-05-10
PH24710A (en) 1990-10-01
NO165543C (no) 1991-02-27
IL83372A0 (en) 1987-12-31
ES2052524T3 (es) 1994-07-16
AU7619687A (en) 1988-03-03
US4888344A (en) 1989-12-19
FI873299A0 (fi) 1987-07-29
MX7534A (es) 1993-10-01
DK399087D0 (da) 1987-07-30
FI88037C (fi) 1993-03-25
DE3781980D1 (de) 1992-11-05
DE3781980T2 (de) 1993-02-18
MX173359B (es) 1994-02-23
NO1997013I1 (no) 1997-10-17
GR3006254T3 (fi) 1993-06-21
LU88635I2 (fr) 1995-12-01
CA1322371C (en) 1993-09-21
NZ221224A (en) 1989-10-27
JPS6434986A (en) 1989-02-06
AR243189A1 (es) 1993-07-30
IE871959L (en) 1988-01-30
FI88037B (fi) 1992-12-15
NO873205D0 (no) 1987-07-30
HU199473B (en) 1990-02-28
HK169595A (en) 1995-11-10
NO873205L (no) 1988-02-01
EP0256377B1 (en) 1992-09-30
DK399087A (da) 1988-01-31

Similar Documents

Publication Publication Date Title
FI873299A (fi) Karbapenemfoerening i kristallform och dess framstaellning och anvaendning.
FI871934A0 (fi) Polyvinylidendifluoridstruktur och foerfarande foer dess framstaellning.
FI880216A (fi) I vaexter verksam fosfinotricinresistensgen och dess anvaendning.
FI870049A0 (fi) Hoelje foer tobaksstaong och komposition foer dess framstaellning.
FI870066A0 (fi) Elektroluminensanordning av tunnfilmstyp och foerfarande foer dess framstaellning.
FI874160A0 (fi) Isolerings- och tyngdhoelje foer undervattensroerledningar och foerfarande foer dess framstaellning.
FI884256A0 (fi) Livsmedelsfoerpackning och foerfarande foer dess framstaellning.
FI872929A0 (fi) Polyolkomposition och dess anvaendning foer framstaellning av flamhaerdiga polyuretanskum.
FI883363A0 (fi) Framstaellning av en t-cellsupressorfaktor och dess anvaendning.
FI874447A0 (fi) Fiskodlingsanordning och foerfarande foer dess framstaellning.
FI883525A (fi) Koettprodukt och dess framstaellningsfoerfarande.
FI872263A (fi) Vaermestabiliserat dipeptidsoetningsmedel och dess anvaendning.
FI870685A (fi) Aminosocker karbonerande aemne och dess framstaellning.
FI874588A0 (fi) Glykolipoid innehaollande n-glykolylneuraminsyra och foerfarande foer dess framstaellning.
FI874784A0 (fi) Slitbestaendigt staol och foerfarande foer dess framstaellning.
FI883877A0 (fi) Rengoeringsmedel foer kontaktlinser och foerfarande foer dess anvaendning.
FI874994A0 (fi) --amylas med reducerad stabilitet och foerfarande foer dess framstaellning.
FI863516A (fi) Balkkonstruktion och foerfarande foer dess framstaellning.
FI875472A (fi) Naethinnestift och foerfarande foer dess implantering.
FI874919A (fi) Aermanordning och foerfarande foer dess framstaellning.
FI864682A0 (fi) Betongvaeg och foerfarande foer dess framstaellning.
FI874119A (fi) 2-metyldecanaloxim och dess anvaendning.
FI871102A (fi) Taeck och vattenisoleringskikt och foerfarande foer dess framstaellning.
FI862832A0 (fi) Moenstrad laminatglasskiva och foerfarande foer dess framstaellning.
FI861592A0 (fi) Maottstabil och taenjbar taeck- och vattenisoleringfilt och foerfarande foer dess framstaellning.

Legal Events

Date Code Title Description
ND Supplementary protection certificate (spc) granted
SPCG Supplementary protection certificate granted

Spc suppl protection certif: L57

Extension date: 20090817

FG Patent granted

Owner name: SUMITOMO PHARMACEUTICALS COMPANY

PC Transfer of assignment of patent

Owner name: DAINIPPON SUMITOMO PHARMA CO., LTD.

Free format text: DAINIPPON SUMITOMO PHARMA CO., LTD.

MA Patent expired